A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis
Clinical trial NCT03025542 · COMPLETED
Trial details
- NCT number
- NCT03025542
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-27
- Primary completion
- 2017-12-11
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.